MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/bdra.20599

Медицинская библиотека · Birth defects research. Part A, Clinical and molecular teratology · 2009

Perspectives of primary care clinicians on teratogenic risk counseling.

Schwarz Eleanor Bimla, Santucci Aimee, Borrero Sonya, Akers Aletha Y, Nikolajski Cara, Gold Melanie A

СтатьяМногоцентровое исследованиеПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

Women of childbearing age are commonly prescribed medications by primary care providers (PCPs) that may cause birth defects if used during pregnancy.

METHODS

To identify what PCPs perceive as barriers to and potential facilitators of providing counseling to women of childbearing age when teratogenic medications are prescribed, we conducted eight focus groups with 48 PCPs recruited from four clinical settings in Pittsburgh, Pennsylvania. We explored PCPs' experiences counseling women about teratogenic medications. Each focus group was audio-recorded, transcribed, and coded using a grounded theory approach by three independent coders.

RESULTS

PCPs feel responsible for counseling women when they prescribe medications that may cause birth defects, but note difficulties identifying clinically relevant sources of information on teratogenicity. Other barriers to providing counseling include limited visit times and lack of reimbursement for preconception or teratogenic risk counseling. PCPs find it challenging to identify patients who may become pregnant and who therefore need contraceptive and/or teratogenic risk counseling. PCPs expressed a desire for online resources that could be used when explaining medication risks to patients. PCPs feel that the development of patient information materials, electronic decision support tools, clinical care systems that routinely assess patients' pregnancy risk, and changes in the reimbursement structure may facilitate counseling patients about teratogenic risks.

CONCLUSIONS

PCPs perceive themselves as playing an important role in providing their patients information on risk of medication-induced birth defects. To ensure safe prescription of teratogenic medications, PCPs suggest interventions at both the clinic and healthcare system levels.

Для цитирования: Schwarz Eleanor Bimla, Santucci Aimee, Borrero Sonya, Akers Aletha Y, Nikolajski Cara, Gold Melanie A. Perspectives of primary care clinicians on teratogenic risk counseling.. Birth defects research. Part A, Clinical and molecular teratology. 2009. DOI: 10.1002/bdra.20599.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.